ID   GALT8_HUMAN             Reviewed;         637 AA.
AC   Q9NY28; B2RU02;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   10-MAY-2017, entry version 129.
DE   RecName: Full=Probable polypeptide N-acetylgalactosaminyltransferase 8;
DE            EC=2.4.1.41;
DE   AltName: Full=Polypeptide GalNAc transferase 8;
DE            Short=GalNAc-T8;
DE            Short=pp-GaNTase 8;
DE   AltName: Full=Protein-UDP acetylgalactosaminyltransferase 8;
DE   AltName: Full=UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 8;
GN   Name=GALNT8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND VARIANTS ASN-53;
RP   GLY-267; SER-312; VAL-337; GLY-438; PHE-515 AND MET-611.
RC   TISSUE=Fetal brain;
RX   PubMed=10767557; DOI=10.1016/S0378-1119(00)00050-0;
RA   White K.E., Lorenz B., Evans W.E., Meitinger T., Strom T.M.,
RA   Econs M.J.;
RT   "Molecular cloning of a novel human UDP-GalNAc:polypeptide N-
RT   acetylgalactosaminyltransferase, GalNAc-T8, and analysis as a
RT   candidate autosomal dominant hypophosphatemic rickets (ADHR) gene.";
RL   Gene 246:347-356(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Probably catalyzes the initial reaction in O-linked
CC       oligosaccharide biosynthesis, the transfer of an N-acetyl-D-
CC       galactosamine residue to a serine or threonine residue on the
CC       protein receptor. {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: UDP-N-acetyl-alpha-D-galactosamine +
CC       polypeptide = UDP + N-acetyl-alpha-D-galactosaminyl-polypeptide.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250};
CC       Single-pass type II membrane protein {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Widely expressed. Expressed in heart, skeletal
CC       muscle, kidney, liver, small intestine and placenta. Weakly
CC       expressed in colon, thymus, spleen, lung and leukocyte.
CC       {ECO:0000269|PubMed:10767557}.
CC   -!- DOMAIN: There are two conserved domains in the glycosyltransferase
CC       region: the N-terminal domain (domain A, also called GT1 motif),
CC       which is probably involved in manganese coordination and substrate
CC       binding and the C-terminal domain (domain B, also called
CC       Gal/GalNAc-T motif), which is probably involved in catalytic
CC       reaction and UDP-Gal binding. {ECO:0000250}.
CC   -!- DOMAIN: The ricin B-type lectin domain binds to GalNAc and
CC       contributes to the glycopeptide specificity. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 2 family. GalNAc-T
CC       subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase;
CC       Note=Probable polypeptide N-acetylgalactosaminyltransferase 8;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_490";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ271385; CAB89199.1; -; mRNA.
DR   EMBL; BC140888; AAI40889.1; -; mRNA.
DR   EMBL; BC140889; AAI40890.1; -; mRNA.
DR   CCDS; CCDS8533.1; -.
DR   RefSeq; NP_059113.1; NM_017417.1.
DR   UniGene; Hs.511985; -.
DR   ProteinModelPortal; Q9NY28; -.
DR   SMR; Q9NY28; -.
DR   IntAct; Q9NY28; 1.
DR   STRING; 9606.ENSP00000252318; -.
DR   CAZy; CBM13; Carbohydrate-Binding Module Family 13.
DR   CAZy; GT27; Glycosyltransferase Family 27.
DR   iPTMnet; Q9NY28; -.
DR   PhosphoSitePlus; Q9NY28; -.
DR   BioMuta; GALNT8; -.
DR   DMDM; 51316106; -.
DR   EPD; Q9NY28; -.
DR   PaxDb; Q9NY28; -.
DR   PeptideAtlas; Q9NY28; -.
DR   PRIDE; Q9NY28; -.
DR   Ensembl; ENST00000252318; ENSP00000252318; ENSG00000130035.
DR   GeneID; 26290; -.
DR   KEGG; hsa:26290; -.
DR   UCSC; uc001qne.2; human.
DR   CTD; 26290; -.
DR   DisGeNET; 26290; -.
DR   GeneCards; GALNT8; -.
DR   HGNC; HGNC:4130; GALNT8.
DR   HPA; HPA012638; -.
DR   HPA; HPA073461; -.
DR   MIM; 606250; gene.
DR   neXtProt; NX_Q9NY28; -.
DR   OpenTargets; ENSG00000130035; -.
DR   PharmGKB; PA28543; -.
DR   eggNOG; KOG3736; Eukaryota.
DR   eggNOG; ENOG410XPMK; LUCA.
DR   GeneTree; ENSGT00670000097647; -.
DR   HOGENOM; HOG000038228; -.
DR   HOVERGEN; HBG051699; -.
DR   InParanoid; Q9NY28; -.
DR   KO; K00710; -.
DR   OrthoDB; EOG091G036Q; -.
DR   PhylomeDB; Q9NY28; -.
DR   TreeFam; TF352661; -.
DR   Reactome; R-HSA-913709; O-linked glycosylation of mucins.
DR   UniPathway; UPA00378; -.
DR   ChiTaRS; GALNT8; human.
DR   GenomeRNAi; 26290; -.
DR   PRO; PR:Q9NY28; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000130035; -.
DR   CleanEx; HS_GALNT8; -.
DR   ExpressionAtlas; Q9NY28; baseline and differential.
DR   Genevisible; Q9NY28; HS.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; TAS:Reactome.
DR   GO; GO:0016266; P:O-glycan processing; TAS:Reactome.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR001173; Glyco_trans_2-like.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   InterPro; IPR000772; Ricin_B_lectin.
DR   Pfam; PF00535; Glycos_transf_2; 1.
DR   Pfam; PF00652; Ricin_B_lectin; 1.
DR   SMART; SM00458; RICIN; 1.
DR   SUPFAM; SSF50370; SSF50370; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
DR   PROSITE; PS50231; RICIN_B_LECTIN; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein; Glycosyltransferase;
KW   Golgi apparatus; Lectin; Manganese; Membrane; Metal-binding;
KW   Polymorphism; Reference proteome; Signal-anchor; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    637       Probable polypeptide N-
FT                                acetylgalactosaminyltransferase 8.
FT                                /FTId=PRO_0000059119.
FT   TOPO_DOM      1      6       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      7     29       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     30    637       Lumenal. {ECO:0000255}.
FT   DOMAIN      496    634       Ricin B-type lectin.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   REGION      180    294       Catalytic subdomain A.
FT   REGION      351    412       Catalytic subdomain B.
FT   METAL       278    278       Manganese. {ECO:0000250}.
FT   METAL       280    280       Manganese. {ECO:0000250}.
FT   METAL       409    409       Manganese. {ECO:0000250}.
FT   BINDING     221    221       Substrate. {ECO:0000250}.
FT   BINDING     255    255       Substrate. {ECO:0000250}.
FT   BINDING     412    412       Substrate. {ECO:0000250}.
FT   BINDING     417    417       Substrate. {ECO:0000250}.
FT   CARBOHYD     85     85       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    107    107       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    160    160       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    171    404       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   DISULFID    395    474       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   DISULFID    509    525       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   DISULFID    556    571       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   DISULFID    599    617       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   VARIANT      53     53       Y -> D (in dbSNP:rs10849133).
FT                                /FTId=VAR_019581.
FT   VARIANT      53     53       Y -> N (in dbSNP:rs10849133).
FT                                {ECO:0000269|PubMed:10767557}.
FT                                /FTId=VAR_019582.
FT   VARIANT     234    234       E -> K (in dbSNP:rs16931676).
FT                                /FTId=VAR_033947.
FT   VARIANT     267    267       E -> G (in dbSNP:rs34776842).
FT                                {ECO:0000269|PubMed:10767557}.
FT                                /FTId=VAR_019583.
FT   VARIANT     312    312       F -> S (in dbSNP:rs34829532).
FT                                {ECO:0000269|PubMed:10767557}.
FT                                /FTId=VAR_019584.
FT   VARIANT     337    337       A -> V (in dbSNP:rs199920896).
FT                                {ECO:0000269|PubMed:10767557}.
FT                                /FTId=VAR_019585.
FT   VARIANT     438    438       D -> G (in dbSNP:rs559663039).
FT                                {ECO:0000269|PubMed:10767557}.
FT                                /FTId=VAR_019586.
FT   VARIANT     515    515       V -> F (in dbSNP:rs1468556).
FT                                {ECO:0000269|PubMed:10767557}.
FT                                /FTId=VAR_019587.
FT   VARIANT     611    611       V -> M (in dbSNP:rs34114277).
FT                                {ECO:0000269|PubMed:10767557}.
FT                                /FTId=VAR_019588.
FT   VARIANT     630    630       D -> G (in dbSNP:rs16931692).
FT                                /FTId=VAR_049241.
SQ   SEQUENCE   637 AA;  72851 MW;  4C8BA5DC9A9A1F64 CRC64;
     MMFWRKLPKA LFIGLTLAIA VNLLLVFSSK GTLQNLFTGG LHRELPLHLN KRYGAVIKRL
     SHLEVELQDL KESMKLALRQ QENVNSTLKR AKDEVRPLLK AMETKVNETK KHKTQMKLFP
     HSQLFRQWGE DLSEAQQKAA QDLFRKFGYN AYLSNQLPLN RTIPDTRDYR CLRKTYPSQL
     PSLSVILIFV NEALSIIQRA ITSIINRTPS RLLKEIILVD DFSSNGELKV HLDEKIKLYN
     QKYPGLLKII RHPERKGLAQ ARNTGWEAAT ADVVAILDAH IEVNVGWAEP ILARIQEDRT
     VIVSPVFDNI RFDTFKLDKY ELAVDGFNWE LWCRYDALPQ AWIDLHDVTA PVKSPSIMGI
     LAANRHFLGE IGSLDGGMLI YGGENVELSL RVWQCGGKVE ILPCSRIAHL ERHHKPYALD
     LTAALKRNAL RVAEIWMDEH KHMVYLAWNI PLQNSGIDFG DVSSRMALRE KLKCKTFDWY
     LKNVYPLLKP LHTIVGYGRM KNLLDENVCL DQGPVPGNTP IMYYCHEFSS QNVYYHLTGE
     LYVGQLIAEA SASDRCLTDP GKAEKPTLEP CSKAAKNRLH IYWDFKPGGA VINRDTKRCL
     EMKKDLLGSH VLVLQTCSTQ VWEIQHTVRD WGQTNSQ
//
